CLINICAL_TRIALS
research
· 2024-06-17
Clinical Trial Update: Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.
Summary
A real-world observational study evaluating naloxegol for opioid-induced constipation in cancer pain patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Opioid Induced Constipation | Status: COMPLETED